COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN/AMLODIPINE FIX-DOSE COMBINATION FOR HYPERTENSIVE PATIENTS IN CHINA

被引：0
|
作者：
Xuan, J. [1 ]
Lu, Y. [2 ]
Xuan, D. [3 ]
Fu, Y. [1 ]
机构：
[1] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China
[2] Shanghai Centennial Sci Co Ltd, Shanghai, Peoples R China
[3] Univ N Carolina, Gillings Global Sch Publ Hlth, Chapel Hill, NC 27515 USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.458
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV22
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [1] A RETROSPECTIVE COST-EFFECTIVENESS ANALYSIS OF S-AMLODIPINE IN CHINA
    Hu, S. L.
    Zhang, Y.
    He, J.
    Du, L.
    VALUE IN HEALTH, 2014, 17 (07) : A758 - A758
  • [2] Effects of an olmesartan/amlodipine combination compared to olmesartan or amlodipine monotherapies on some insulin resistance parameters in hypertensive patients
    Derosa, G.
    Cicero, A. F. G.
    D'Angelo, A.
    Bonaventura, A.
    Bianchi, L.
    Romano, D.
    Maffioli, P.
    EUROPEAN HEART JOURNAL, 2013, 34 : 336 - 336
  • [3] Olmesartan/Amlodipine Combination Versus Olmesartan or Amlodipine Monotherapies on Blood Pressure and Insulin Resistance in a Sample of Hypertensive Patients
    Derosa, Giuseppe
    Cicero, Arrigo F. G.
    Carbone, Anna
    Querci, Fabrizio
    Fogari, Elena
    D'Angelo, Angela
    Maffioli, Pamela
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (05) : 301 - 307
  • [4] Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy
    Jun-Ren Zhu
    Shu-Yang Zhang
    Ping-Jin Gao
    Archives of Pharmacal Research, 2014, 37 : 1588 - 1598
  • [5] Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy
    Zhu, Jun-Ren
    Zhang, Shu-Yang
    Gao, Ping-Jin
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (12) : 1588 - 1598
  • [6] Cost-effectiveness of a fixed-dose combination agent in high-risk hypertensive patients
    Faulkner, MA
    Hilleman, DE
    Reyes, AP
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 105A - 105A
  • [7] Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice
    Bramlage, Peter
    Wolf, Wolf-Peter
    Stuhr, Thomas
    Fronk, Eva-Maria
    Erdlenbruch, Wolfhard
    Ketelhut, Reinhard
    Schmieder, Roland E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 803 - 811
  • [8] Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
    Bramlage, Peter
    Fronk, Eva-Maria
    Wolf, Wolf-Peter
    Smolnik, Ruediger
    Sutton, Gemma
    Schmieder, Roland E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 1 - 8
  • [9] A cost-effectiveness analysis of olmesartan in the treatment of arterial hypertension
    Lamotte, M.
    Annemans, L.
    Van Loy, R.
    Koch, W.
    VALUE IN HEALTH, 2006, 9 (06) : A347 - A347
  • [10] Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China
    Ren, Maodong
    Xuan, Dennis
    Lu, Yongji
    Fu, YuYan
    Xuan, Jianwei
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 394 - 400
12345